Innovagen

Innovagen is a long-established, privately-held Swedish contract research organization (CRO) focused on antibody and peptide services. Operating from the IDEON Science Park in Lund, the company leverages its deep expertise to offer a full suite of services including antibody development, engineering, modification, production, and characterization for clients in the biopharmaceutical and research sectors. Its business model is purely service-based, generating revenue by acting as an extension of its clients' R&D teams, with no proprietary therapeutic pipeline of its own. The company benefits from its location within a strong Scandinavian biotech ecosystem but faces competition from larger global CROs.

Integrated service platform for antibody development (discovery, engineering, modification, production, characterization) and custom peptide/protein synthesis.

Operates in the crowded contract research organization (CRO) market for biologics. Competes with large, full-service CROs (e.g., Lonza, Thermo Fisher) and numerous specialized boutique firms offering similar antibody and peptide services. Differentiation is based on deep technical expertise, customization, and a partnership model.